Tirzepatide emerges a groundbreaking pharmaceutical agent for individuals battling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent https://polaris-peptide.com/product-category/tirzepatide-peptide/